hotspot -WSS

hotspot

author：hotspot 2025-09-27 23:32:41 - browse：18725

a photo of the federal trade commission building — Alex Brandon/AP

The federal government is suing to block a proposed hospital deal in North Carolina, alleging it would hand control of over 65% of the inpatient market in the region to a single provider.

Novant Health’s proposed acquisition of two nearby hospitals is precisely the kind of case antitrust experts would expect the Federal Trade Commission to take on because it would make an already large regional player, Novant, even more powerful. And even though smaller deals like this get less attention than huge, 100-plus hospital mergers, they can still drive up people’s insurance premiums and medical bills.

In this case, Novant, a nonprofit system with $7.6 billion in 2022 revenue, plans to buy two hospitals in the same county from the for-profit chain Community Health Systems for $320 million. The two hospitals, Lake Norman Regional Medical Center and Davis Regional Medical Center, are only about a 25-minute drive from one another. A Novant spokesperson called the FTC’s position flawed and said the system will pursue available legal responses. CHS spokesperson Tomi Galin wrote in an email that a judge will make the final determination on whether the transaction can proceed and thanked staff for continuing to deliver quality care during the regulatory process.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： STAT Readout Newsletter: Biotech news today

focus

WSS

Why do women spend more than men on medical expenses?

STAT Summit: Ending the crisis of Black deaths in the U.S.

Shingles, which affected Dianne Feinstein, is on the rise

Health tech investors get more selective as pandemic boom fades

Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

Paxlovid should be available without a positive Covid test

hotspot

hotspot

Wikipedia

Psychedelics group wrestles with new pharma identity

Mindstrong's demise and the future of mental health care

How to save PrEP access — and even expand it

Mindstrong's demise and the future of mental health care

In age of alternative facts, a scholarly course on calling out crap

Smaller biotechs seek to piggyback on weight loss drug boom

Alkermes shareholders re

The future of Biogen: Pragmatism, ‘moonshots,’ and no Twinkies

In Memoriam: Notable people who died in 2023

STAT Summit: How researchers deal with rejection

Wikipedia

Is there really a nursing shortage in the U.S.?

Intercept Pharmaceuticals sells itself for less than $1 billion

Study on Amgen’s bispecific immunotherapy produces positive data

Cigna to pay $172 million to settle Medicare Advantage fraud probe

WHO recommends dropping component of many flu vaccines

UnitedHealth, Optum discontinue NaviHealth name

focus

hotspot

knowledge

hotspot